Amgen Inc. (AMGN)

$ 0.00
   
  • Closing Price Chg:
    $23.16
  • 52 Week High: $327.36
  • 52 Week Low: $258.59
  • Currency: US Dollars
  • Shares Issued: 536.90m
  • Volume: 0
  • RiskGrade: 100

Latest ShareCast News

EU approves AstraZeneca's Tezspire to treat nasal conditions

By Frank Prenesti

Date: Monday 22 Sep 2025

(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Amgen Inc. Market Data

Currency US Dollars
Share Price $ 319.86
Closing Price Change $ 23.16
% Change 0.00 %
52 Week High $327.36
52 Week Low $258.59
Volume 0
Shares Issued 536.90m
RiskGrade 100

What The Brokers Say

Strong Buy 6
Buy 7
Neutral 15
Sell 2
Strong Sell 1
Total 31
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 06-Nov-2025

Time Volume / Share Price
13:09 40 @ $317.02
13:09 120 @ $317.08
13:09 40 @ $317.02
13:09 57 @ $317.02
13:09 50 @ $317.02

Top of Page